Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma
Authors:
- Lucia TixiLTLucia Tixi
- Fiorenza LatteriFLFiorenza Latteri
- Sergio BrettiSBSergio Bretti
- Marco AlloisioMAMarco Alloisio
- Adriano GravinaAGAdriano Gravina
- Rita LionettoRLRita Lionetto
- Paolo BruzziPBPaolo Bruzzi
- Carla DaniCDCarla Dani
- Riccardo RossoRRRiccardo Rosso
- Maurizio CossoMCMaurizio Cosso
- Luca BalzariniLBLuca Balzarini
- Armando SantoroASArmando Santoro
Open Access
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesotheliomaCancer, 1997
- Chemotherapy in malignant pleural mesothelioma. A review.Journal of Clinical Oncology, 1996
- Recombinant Interferon Alpha-2b in the Treatment of Diffuse Malignant Pleural MesotheliomaAmerican Journal of Clinical Oncology, 1994
- Natural History and Epidemiology of Malignant MesotheliomaChest, 1993
- Effect of Interferon-α 2a Malignant MesotheliomaJournal of Interferon Research, 1993
- Interferon-α and -γ in combination with chemotherapeutic drugsAnti-Cancer Drugs, 1992
- The role of extrapleural pneumonectomy in malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 1991
- Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II studyCancer, 1991
- Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.Journal of Clinical Oncology, 1988
- Interferon Therapy for Neoplastic Diseases in Man In Vitro and In Vivo Studies1978